Amgen (NASDAQ:AMGN) Price Target Raised to $294.00
Amgen (NASDAQ:AMGN – Free Report) had its price objective raised by Bank of America from $275.00 to $294.00 in a report released on Wednesday morning,Benzinga reports. Bank of America currently has an underperform rating on the medical research company’s stock. Several other analysts also recently weighed in on AMGN. Citigroup reaffirmed a “neutral” rating on […]
Amgen (NASDAQ:AMGN – Free Report) had its price objective raised by Bank of America from $275.00 to $294.00 in a report released on Wednesday morning,Benzinga reports. Bank of America currently has an underperform rating on the medical research company’s stock. Several other analysts also recently weighed in on AMGN. Citigroup reaffirmed a “neutral” rating on […]
